EUVIMEDEUVIMED entdecken
Crossref

Allelic variants and immunostaining profile in CXCL12/CXCR4 axis: An investigation of association with prognosis in prostate cancer

Amanda Letícia Francelino, Érica Romão Pereira, Laís Capelasso Lucas Pinheiro, Adrielli Caroline Soares, Ana Carla Mendonça, Paulo Emílio Fuganti, Wilson Frantine-Silva, Karen Brajão de Oliveira, Juliana Mara Serpeloni, Roberta Losi Guembarovski

Pathology - Research and Practice · 2023

DOI: 10.1016/j.prp.2023.154806 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology - Research and Practice, 2023. Verfasst von Amanda Letícia Francelino und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Mutagenesis and Oncogenetics, Department of General Biology, Londrina State University, Londrina, PR, Brazil. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Receptors, CXCR4, Chemokine CXCL12, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer (PCa) is the malignant neoplasm that most commonly affects men and is an important cause of death. It can be detected by changes in serum levels of Prostate Specific Antigen (PSA) and digital rectal examination, but often symptoms do not appear until advanced stages and metastases. The C-X-C Motif Chemokine Ligand 12/C-X-C Motif Chemokine Receptor 4 (CXCL12/CXCR4) axis acts in cell migration and may be involved in the metastatic process. In this context, the aim of this study was to evaluate the allelic variants rs1801157 (CXCL12) and rs2228014 (CXCR4) and the immunostaining of CXCR4 protein as candidates for prognostic markers in PCa. Samples (n = 60) were divided according to prognostic parameters (with and without metastasis at diagnosis) in tree groups: better prognosis, worse prognosis with metastasis at diagnosis and worse prognosis without metastasis at diagnosis, and immunostaining was evaluated by indirect immunohistochemistry, considering tumoral and adjacent tissues from the same patient (n = 120). A significant association was found between the C allele of rs2228014 (CXCR4) and the extraprostatic extension. For CXCR4 immunostaining a weak labeling and a cytoplasmic localization predominated, as well as a significant difference between malignant versus adjacent tissue, with higher protein expression in the malignant tissue. A significant association was found between CXCR4 tumor immunostaining with TNM staging (T2b-T2c) and PSA level (> 20 ng/mL). None of the allelic variants affected CXCR4 immunostaining. Prognostic groups did not differ in allelic variant frequency or immunostaining profile. Findings suggest that CXCR4 receptor may be one of the ways to worsen the prognosis of prostatic cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsReceptors, CXCR4Chemokine CXCL12Biomarkers, TumorHumansMalePrognosisAgedMiddle AgedAllelesImmunohistochemistryPolymorphism, Single NucleotideAged, 80 and over

Stichwörter der Autor:innen

Genetic polymorphismImmunohistochemistryRs1801157 (CXCL12)Rs2228014 (CXCR4)

Substanzen

Receptors, CXCR4CXCR4 protein, humanChemokine CXCL12CXCL12 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Laboratory of Mutagenesis and Oncogenetics, Department of General Biology, Londrina State University, Londrina, PR, Brazil.
  • Cancer Hospital of Londrina - HCL, Londrina, PR, Brazil.
  • Laboratory of Studies and Applications of DNA Polymorphism, Department of Immunology, Parasitology and General Pathology, CCB, Londrina State University, Londrina, PR, Brazil.
  • Laboratory of Molecular Genetics and Immunology, Department of Pathological Sciences, Londrina State University, Londrina, PR, Brazil; Laboratory of Studies and Applications of DNA Polymorphism, Department of Immunology…
  • Laboratory of Mutagenesis and Oncogenetics, Department of General Biology, Londrina State University, Londrina, PR, Brazil. Electronic address: robertalosi@uel.br.

Zitieren

APA

Francelino, A. L., Pereira, É. R., Pinheiro, L. C. L., Soares, A. C., Mendonça, A. C., Fuganti, P. E., Frantine-Silva, W., de Oliveira, K. B., Serpeloni, J. M., & Guembarovski, R. L. (2023). Allelic variants and immunostaining profile in CXCL12/CXCR4 axis: An investigation of association with prognosis in prostate cancer. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2023.154806

Vancouver

Francelino AL, Pereira ÉR, Pinheiro LCL, Soares AC, Mendonça AC, Fuganti PE, et al. Allelic variants and immunostaining profile in CXCL12/CXCR4 axis: An investigation of association with prognosis in prostate cancer. Pathology - Research and Practice. 2023. doi:10.1016/j.prp.2023.154806

BibTeX
@article{Francelino2023,
  author = {Francelino, Amanda Letícia and Pereira, Érica Romão and Pinheiro, Laís Capelasso Lucas and Soares, Adrielli Caroline and Mendonça, Ana Carla and Fuganti, Paulo Emílio and Frantine-Silva, Wilson and de Oliveira, Karen Brajão and Serpeloni, Juliana Mara and Guembarovski, Roberta Losi},
  title = {Allelic variants and immunostaining profile in CXCL12/CXCR4 axis: An investigation of association with prognosis in prostate cancer},
  journal = {Pathology - Research and Practice},
  year = {2023},
  doi = {10.1016/j.prp.2023.154806}
}
Kostenlos starten →